Corrected QT interval (QTc) prolongation during phenol-croton oil peels. Boxplots of the differences from baseline during peak increase in QTc during the procedure and 15-minute-postpeel QTc.
Prolongation of rate-corrected QT interval during phenol-croton oil peels To the Editor: Phenol-croton oil chemical peeling has demonstrated marked improvements in skin rejuvenation. 1 Minor arrhythmic events, both supraventricular (isolated atrial extrasystolic beats and supraventricular tachycardia) and ventricular ( premature ventricular beats, ventricular bigeminy, and nonsustained ventricular tachycardia), 2 may occur despite the existing safety guidelines to prevent dysrhythmic events (a 10 minute-pause between cosmetic units, adequate room ventilation, and intravenous saline). 2 The present study was motivated by a case of intraoperative torsades de pointes (TdP) regardless of normal rate-corrected QT interval (QTc) (406 ms) in the preoperative 12-lead electrocardiogram (ECG) in a patient taking drugs known to prolong the QTc (a thiazide diuretic and a tricyclic antidepressant). TdP is known to be associated with prolonged QTc and may cause sudden death by degeneration into ventricular fibrillation. 3 The QT interval is a measure of the duration of ventricular repolarization. Drugs may cause a repolarization delay (drug-induced QTc prolongation), with the following commonly used drugs triggering this phenomenon: antiemetics ( prescribed for opioid-induced nausea), analgesics, antibiotics, antifungals, diuretics, antipsychotics, and antidepressants. 3 Prolonged QTc is usually defined as longer more than 450 ms or an increase from baseline of 20 to 30 ms. 4 A markedly prolonged QTc is defined as longer than 500 ms or when there is an increase from baseline greater than 60 ms. 4 This study's objective was to evaluate dynamic changes in QTc prolongation during phenol-croton oil peels.
QTc was evaluated 30 minutes before and after the procedure by ECG and at intraoperative intervals of 10 minutes by Holter monitoring in 10 consecutive patients peeled with Hetter formulas 5 (unoccluded 0.4% to 1.6% croton oil in 35% phenol), which are theoretically safer than the Baker formula (2.1% croton oil in 50% phenol). 5 The Fridericia correction (QTc ¼ QT/RR 0.33 , where RR is the interval between successive upward peaks of ventricular depolarization on the ECG.) was used following the recommendation of the US Food and Drugs Administration. 4 The Wilcoxon signed rank test was used to analyze statistical differences between baseline and peak, and every 10 minutes of intraoperative QTc. P less than .05 was considered significant.
The 1 male patient showed minimal QTc elevation (\20 ms). The other 9 patients (all female) presented varied degrees of QTc prolongation: 3 patients presented mild prolongation of 20 to 30 ms (the only 3 localized peels), 4 patients presented prolongation of 30 to 60 ms ( full-face or neck peels), and 2 patients presented marked prolongation longer than 60 ms ( full-face peels). No patient had prolongation exceeding 500 ms, but in 3 patients prolongation exceeded 480 ms. Two patients presented no arrhythmic events (both had \30 ms of prolongation and \430 ms of peak QTc). Eight patients presented minor arrhythmic events such as extrasystolic beats and nonsustained supraventricular tachycardia, which occurred mostly by the peak of QTc and/or by the end of the procedure. A significant statistical difference was found from baseline to peak QTc (P ¼ .005), 10 minutes (P ¼ .005), 20 minutes (P ¼ .005), 30 minutes (P ¼ .007), 60 minutes (P ¼ .028), and 70 minutes (P ¼ .028). No statistical difference was found from baseline to 15 minutes after the peel (P ¼ .68) (Fig 1) or in QTc evaluated by 12-lead ECG 30 minutes before and 30 minutes after the procedure (P ¼ 1.0).
Phenol-croton oil peeling was associated with transient intraoperative QTc prolongation without clinically significant arrhythmia. Given the risk of TdP, the interaction between phenol and medications associated with QTc prolongation deserves further studies to determine safety parameters in deep peeling. 1 reported that biopsies from blaschkoid variants of epidermolytic hyperkeratosis (EHK) showed focal changes with skip areas of normal epidermis in contrast to nonmosaic variants, which showed continuous changes. We have noticed similar focal histologic involvement in other blaschkoid disorders with epidermal changes. In this study, we aimed to explore the prevalence of this histologic pattern in different blaschkoid dermatoses.
Carlos
We screened the skin biopsy records at our hospital from January 2014 to June 2016 for blaschkoid dermatoses with epidermal histologic changes and for nonmosaic, generalized dermatoses to serve as controls, where available. Slides were evaluated by 2 dermatopathologists blinded to the clinical information. We retrieved 61 slides of blaschkoid disorders and 79 controls. Histologic changes characteristic of the clinical diagnosis were seen in 48 of 61 biopsies (78.7%) from blaschkoid dermatoses. In another 5 cases in which the clinical diagnosis was not conclusive, histologic features of inflammatory linear verrucous epidermal nevus (ILVEN) and EHK were noted in 1 case each and increased basilar pigmentation was seen in 3 cases. We excluded the remaining 8 cases in which histopathologic changes were nondiagnostic. Focal changes were seen in 20 of 53 biopsies (37.7%): ILVEN in 7 of 9 biopsies (77.8%), EHK in 5 of 7 (71.4%), verrucous epidermal nevus (VEN) in 2 of 5 (40%), linear porokeratosis in 1 of 4 (25%), linear Darier's disease in 1 of 1 (100%), linear psoriasis in 1 of 1 (100%), and hyperpigmentary blaschkoid disorders in 3 of 3 (100%) (Fig 1) . The alternating changes were those of the underlying disease in all cases except 2. In linear porokeratosis, compact 
